[This Week's IPO] Bookbuilding and Subscription Schedule for the First Week of November View original image

In the first week of November, Davio, Hana Aerodynamics, MBD, J&TG, and C&M will conduct bookbuilding for institutional investors. Dongwon Parts, Baropharm, NexEye, Youngkwang YKMC, Optonics, and AL Robot are set to hold public offerings.


<Bookbuilding>


◆Davio= Davio's core platform, "Eartheye," is an AI-powered geospatial solution that automatically detects changes over time and space based on satellite, aerial, and drone imagery. It uses a "Sensor-Aware Change Detection Engine" based on Davio's GEO AI model to remove pseudo changes caused by differences in lighting or seasons and deliver precise analytical results.


The company plans to offer a total of 1 million shares. The indicative offering price is KRW 12,300-16,600 per share. Bookbuilding for institutional investors will run from Nov. 2 to 6, followed by the public offering subscription on Nov. 10-11. Daishin Securities is the lead manager.


◆Hana Aerodynamics= Founded in 2007, Hana Aerodynamics is an aerospace manufacturing company that handles everything from jig and fixture design and production to precision parts machining and airframe structural assembly. It supplies jigs and fixtures, components, and assembled structures for commercial aircraft, military aircraft, and helicopters to domestic and international clients, including Korea Aerospace Industries (KAI) and Bell Helicopter.


The company plans to offer a total of 4.4 million shares at an indicative price range of KRW 4,700-5,700 per share. The total offering is expected to raise KRW 20.7 billion-25.8 billion. Bookbuilding for institutional investors is scheduled for Nov. 2-6, followed by the public offering subscription on Nov. 10-11. IBK Securities is the lead manager.


◆MBD= Founded in 2015, MBD is a bio-platform company targeting both the precision medicine and new drug development markets with technologies for automating and standardizing 3D cell culture. The company has adapted precision control and automation technologies used in semiconductor and electronic component manufacturing to 3D cell culture, turning a process that once relied on researchers' manual work into a standardized, equipment-based process.


The company plans to offer a total of 2 million shares at an indicative price of KRW 9,600-11,700 per share. It will conduct bookbuilding for institutional investors from Nov. 2 to 6 and set the final offering price, then hold the public offering subscription on Nov. 12-13. It aims to list on the KOSDAQ in November. Hana Securities is the lead manager.


◆J&TG= J&TG develops and manufactures carbon materials used in energy storage, utilization, and production, including non-lithium secondary-battery energy storage systems (ESS), hydrogen fuel cells, and water electrolysis. Its distinguishing feature is an in-house production system that covers everything from materials development and process design to mass production. Fueled by expanded supply to global customers, its revenue grew at an average annual rate of 88.8% from 2021 to 2025.


The company plans to offer a total of 4.3 million shares at an indicative price of KRW 26,400-31,900 per share. Bookbuilding for institutional investors will run for five business days, from Nov. 3 to 9. The company will then finalize the offering price and hold the public offering subscription on Nov. 12-13. Daishin Securities is the lead manager, and NH Investment & Securities is the co-manager.


◆C&M= Drawing on 45 years of motor technology and in-house development of core processes, C&M has established itself as a major supplier to key customers of motor components for electric compressors, SBW, and EPS. Long-term orders for electric compressors and automotive electronics products, together with increased supply to major customers, have lifted its order backlog to KRW 1.4659 trillion, about 6.1 times last year's revenue, strengthening its growth visibility.


The company plans to offer a total of 2.95 million shares at an indicative price range of KRW 10,000-13,000 per share. The total offering is expected to raise KRW 29.5 billion-38.3 billion. Bookbuilding for institutional investors is scheduled for Nov. 3-9, followed by the public offering subscription on Nov. 12-13. Korea Investment & Securities is the lead manager.


<Public Offering Subscription>


◆Dongwon Parts= The company has set its offering price at KRW 26,500, the top of its indicative price range. A total of 2,236 institutions participated in bookbuilding, resulting in a subscription ratio of 840.9 to 1. Of the participating institutional investors, 99.8% (2,233 bids) offered prices at or above the top of the price range of KRW 23,000-26,500. Shares representing 16.6% of the total shares subscribed for were subject to lock-up commitments.


Dongwon Parts plans to offer a total of 2.03 million shares. The subscription will take place on Nov. 2 and 3, and the company is scheduled to list on the KOSDAQ on Nov. 10. Samsung Securities is the lead manager for the listing.


Dongwon Parts is a company with a portfolio of key components for front-end semiconductor equipment, built on its specialized precision machining technology for advanced materials. Its main products include showerheads, chamber components, heaters, and spin chucks. The company has established a stable revenue structure by supplying both components used in new semiconductor equipment and consumables needed to maintain existing equipment. Its major customers include SEMES, Lam Research, and Applied Materials.


◆Baropharm= The company has set its final offering price at KRW 16,400. Following the public offering subscription for individual investors on Nov. 2-3, it is scheduled to list on the KOSDAQ on Nov. 11. Mirae Asset Securities is the lead manager.


Founded in 2019, Baropharm is an integrated pharmacy platform company established by CEO Kim Seulgi, a practicing pharmacist, to address inefficiencies in pharmacies' ordering and inventory management of medicines. It has built a nationwide pharmacy network with more than 90% of pharmacies in South Korea as members. Its cumulative transaction value stands at KRW 7 trillion, and its reorder rate is 86%.


◆NexEye= The company has set its final offering price at KRW 8,000. The total offering is KRW 40 billion, and its market capitalization after listing is expected to be around KRW 366.8 billion. Following the public offering subscription on Nov. 3-4, it is scheduled to list on the KOSDAQ on Nov. 12. Korea Investment & Securities is the lead manager.


Founded in 2021, NexEye is developing antibody therapeutics by identifying new targets involved in cases where patients do not respond to immuno-oncology treatment or develop resistance during treatment. The company has built its own drug development pipeline based on research into the tumor microenvironment, which limits the efficacy of existing immuno-oncology drugs, and the mechanisms behind resistance to such drugs.


◆Youngkwang YKMC= The indicative offering price is KRW 9,400-11,000 per share, with the planned offering expected to raise approximately KRW 21.6 billion-25.3 billion. Bookbuilding will continue through Nov. 2. Following the public offering subscription on Nov. 4-5, the company is scheduled to list on the KOSDAQ by the end of 2026. Daishin Securities is the lead manager.


Founded in 1989, Youngkwang YKMC operates in precision machining, specialized surface treatment, and precision cleaning, focusing on key components for semiconductor and display manufacturing equipment. It has secured core technologies required for advanced processes, including precision machining of large chambers and ultra-precision five-axis composite machining; ultra-precision surface finishing for vacuum sealing; large-area, high-corrosion-resistance and plasma-resistant anodizing and plating; and ultra-high vacuum (UHV) precision cleaning.


◆Optonics= The company has set its final offering price at KRW 12,000, the top of its indicative range of KRW 10,000-12,000. A total of 2,317 domestic and international institutions participated in bookbuilding, resulting in a subscription ratio of 1,201.81 to 1. Bids covering 100% of the subscribed shares offered prices at or above the top of the range, including bids that did not specify a price. Institutional investors' lock-up commitment ratio was approximately 5.62% based on the number of shares applied for. The public offering subscription is scheduled for Nov. 5-6. Korea Investment & Securities is the lead manager.


Founded in 2004, Optonics specializes in developing and manufacturing optical components for gyroscopes, a key component of inertial navigation systems (INS). It is the only company in South Korea mass-producing components for both ring laser gyroscopes (RLG) and fiber-optic gyroscopes (FOG). The components it supplies are used in major weapons systems, including multiple rocket launchers, surface-to-air guided weapons, and tanks, through its key customers' inertial navigation systems.


◆AL Robot= The indicative offering price is KRW 15,700-17,600 per share, and the total offering is expected to raise KRW 37.7 billion-42.2 billion. Bookbuilding for institutional investors will run through Nov. 3, followed by the public offering subscription on Nov. 6-9. Daishin Securities is the lead manager for the listing.



Founded in 2017, AL Robot is a company specializing in core robotics components. Based on its independently developed high-precision sensor and sensor-fusion control technologies, it develops and supplies everything from sensors that detect force and contact information to control devices that precisely manage robot movement.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing